Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

"World's smallest neurostimulator" approved in Australia for chronic pain

This article was originally published in Clinica

Executive Summary

St Jude Medical's Eon Mini neurostimulator has been approved by the Australian Therapeutic Goods Administration for chronic pain. The matchbox-sized Eon Mini, which the St Paul, Minnesota firm claims is the world's smallest and longest-lasting rechargeable device in its class, will be used to treat chronic pain of the trunk or limbs and pain from failed back surgery. It is typically implanted in a patient's lower back, and connected to electrical leads which are placed near the spinal cord. These deliver electrical pulses to interrupt or mask the pain signal as it travels to the brain. Eon Mini received US FDA approval and was CE marked for sale in Europe in April 2008.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT042021

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel